Description: Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19.
Home Page: www.biophytis.com
BPTS Technical Analysis
Sorbonne University
Paris,
75005
France
Phone:
33 1 44 27 23 00
Officers
| Name | Title |
|---|---|
| Mr. Stanislas Veillet Ph.D. | Chairman & CEO |
| Mr. Philippe J. Rousseau | Chief Financial Officer |
| Mr. Waly Dioh | Chief Operating Officer |
| Dr. Pierre J. Dilda | Chief Scientific Officer |
| Dr. Rene Lafont | Scientific Advisor & Member of Scientific Advisory Board |
| Mr. Benoit Canolle | Chief Bus. Officer |
| Mr. Rob van Maanen FFPM, M.B.A., M.D. | Chief Medical Officer |
| Ms. _ Teylan | Financial Controller |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3528 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-02-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 26 |